Patent 8101576 was granted and assigned to Imperial Innovations on January, 2012 by the United States Patent and Trademark Office.
The invention features peptides for the treatment or prevention of obesity, diabetes or co-morbidities of obesity; for reduction of appetite, food intake, calorie intake, body weight, or body weight gain; and for increase of energy expenditure in a subject.